Industry: Medical Devices & Consumables
Published Date: 2026-01-05
Pages: 101 Pages
Report ld: 5508774
Request Sample
Customized Report
Hemoperfusion Cartridge Market Size(US$)

CAGR 2026-2032
16.8%
Market Size,2032
USD 3,163
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Hemoperfusion Cartridge was estimated to be worth US$ 1082 million in 2025 and is projected to reach US$ 3163 million, growing at a CAGR of 16.8% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Hemoperfusion Cartridge cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
The hemoperfusion device (that is, the disposable hemoperfusion device) is an essential key medical device for hemoperfusion.
During hemoperfusion (HP), blood circulates through an extracorporeal circuit equipped with a charcoal or resin cartridge onto which the poison can be adsorbed.
The global top five hemoperfusion cartridge manufacturers include Baxter International, Baihe Medical, Asahi Kasei Corporation, Toray Medical, and Jafron Biomedical, which together account for more than 90% of the market share. The largest manufacturer is Baxter International, with a market share of more than 50%. The Asia-Pacific region is the global most important consumer market for hemoperfusion cartridge, with a market share of more than 75%. In terms of type, resin adsorption has a market share of over 85%. In the field of application, the market share of hospitals has reached more than 80%.
This report provides a comprehensive view of the global market for Hemoperfusion Cartridge, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Hemoperfusion Cartridge market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Hemoperfusion Cartridge.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Hemoperfusion Cartridge manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Hemoperfusion Cartridge sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Hemoperfusion Cartridge sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Hemoperfusion Cartridge Product Introduction
1.2 Global Hemoperfusion Cartridge Market Size Forecast
1.2.1 Global Hemoperfusion Cartridge Sales Value (2021–2032)
1.2.2 Global Hemoperfusion Cartridge Sales Volume (2021–2032)
1.2.3 Global Hemoperfusion Cartridge Sales Price (2021–2032)
1.3 Hemoperfusion Cartridge Market Trends & Drivers
1.3.1 Hemoperfusion Cartridge Industry Trends
1.3.2 Hemoperfusion Cartridge Market Drivers & Opportunities
1.3.3 Hemoperfusion Cartridge Market Challenges
1.3.4 Hemoperfusion Cartridge Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hemoperfusion Cartridge Players Revenue Ranking (2025)
2.2 Global Hemoperfusion Cartridge Revenue by Company (2021–2026)
2.3 Global Hemoperfusion Cartridge Sales Volume Ranking of Players (2025)
2.4 Global Hemoperfusion Cartridge Sales Volume by Company (2021–2026)
2.5 Global Hemoperfusion Cartridge Average Price by Company (2021–2026)
2.6 Key Manufacturers Hemoperfusion Cartridge Manufacturing Base and Headquarters
2.7 Key Manufacturers Hemoperfusion Cartridge Product Offerings
2.8 Key Manufacturers Start of Mass Production of Hemoperfusion Cartridge
2.9 Hemoperfusion Cartridge Market Competitive Analysis
2.9.1 Hemoperfusion Cartridge Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Hemoperfusion Cartridge Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Hemoperfusion Cartridge revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Hemoperfusion Cartridge Market Classification
3.1 Introduction by Type
3.1.1 Activated Carbon Adsorption
3.1.2 Resin Adsorption
3.1.3 Global Hemoperfusion Cartridge Sales Value by Type
3.1.3.1 Global Hemoperfusion Cartridge Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Hemoperfusion Cartridge Sales Value, by Type (2021–2032)
3.1.3.3 Global Hemoperfusion Cartridge Sales Value, by Type (%), 2021–2032
3.1.4 Global Hemoperfusion Cartridge Sales Volume by Type
3.1.4.1 Global Hemoperfusion Cartridge Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Hemoperfusion Cartridge Sales Volume, by Type (2021–2032)
3.1.4.3 Global Hemoperfusion Cartridge Sales Volume, by Type (%), 2021–2032
3.1.5 Global Hemoperfusion Cartridge Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Hemoperfusion Cartridge Sales Value by Application
4.2.1 Global Hemoperfusion Cartridge Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Hemoperfusion Cartridge Sales Value, by Application (2021–2032)
4.2.3 Global Hemoperfusion Cartridge Sales Value, by Application (%), 2021–2032
4.3 Global Hemoperfusion Cartridge Sales Volume by Application
4.3.1 Global Hemoperfusion Cartridge Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Hemoperfusion Cartridge Sales Volume, by Application (2021–2032)
4.3.3 Global Hemoperfusion Cartridge Sales Volume, by Application (%), 2021–2032
4.4 Global Hemoperfusion Cartridge Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Hemoperfusion Cartridge Sales Value by Region
5.1.1 Global Hemoperfusion Cartridge Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Hemoperfusion Cartridge Sales Value by Region (2021–2026)
5.1.3 Global Hemoperfusion Cartridge Sales Value by Region (2027–2032)
5.1.4 Global Hemoperfusion Cartridge Sales Value by Region (%), 2021–2032
5.2 Global Hemoperfusion Cartridge Sales Volume by Region
5.2.1 Global Hemoperfusion Cartridge Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Hemoperfusion Cartridge Sales Volume by Region (2021–2026)
5.2.3 Global Hemoperfusion Cartridge Sales Volume by Region (2027–2032)
5.2.4 Global Hemoperfusion Cartridge Sales Volume by Region (%), 2021–2032
5.3 Global Hemoperfusion Cartridge Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Hemoperfusion Cartridge Sales Value, 2021–2032
5.4.2 North America Hemoperfusion Cartridge Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Hemoperfusion Cartridge Sales Value, 2021–2032
5.5.2 Europe Hemoperfusion Cartridge Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Hemoperfusion Cartridge Sales Value, 2021–2032
5.6.2 Asia Pacific Hemoperfusion Cartridge Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Hemoperfusion Cartridge Sales Value, 2021–2032
5.7.2 South America Hemoperfusion Cartridge Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Hemoperfusion Cartridge Sales Value, 2021–2032
5.8.2 Middle East & Africa Hemoperfusion Cartridge Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hemoperfusion Cartridge Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Hemoperfusion Cartridge Sales Value and Sales Volume
6.2.1 Key Countries/Regions Hemoperfusion Cartridge Sales Value, 2021–2032
6.2.2 Key Countries/Regions Hemoperfusion Cartridge Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Hemoperfusion Cartridge Sales Value, 2021–2032
6.3.2 United States Hemoperfusion Cartridge Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Hemoperfusion Cartridge Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Hemoperfusion Cartridge Sales Value, 2021–2032
6.4.2 Europe Hemoperfusion Cartridge Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Hemoperfusion Cartridge Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Hemoperfusion Cartridge Sales Value, 2021–2032
6.5.2 China Hemoperfusion Cartridge Sales Value by Type (%), 2025 vs 2032
6.5.3 China Hemoperfusion Cartridge Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Hemoperfusion Cartridge Sales Value, 2021–2032
6.6.2 Japan Hemoperfusion Cartridge Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Hemoperfusion Cartridge Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Hemoperfusion Cartridge Sales Value, 2021–2032
6.7.2 South Korea Hemoperfusion Cartridge Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Hemoperfusion Cartridge Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Hemoperfusion Cartridge Sales Value, 2021–2032
6.8.2 Southeast Asia Hemoperfusion Cartridge Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Hemoperfusion Cartridge Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Hemoperfusion Cartridge Sales Value, 2021–2032
6.9.2 India Hemoperfusion Cartridge Sales Value by Type (%), 2025 vs 2032
6.9.3 India Hemoperfusion Cartridge Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Baxter International
7.1.1 Baxter International Company Information
7.1.2 Baxter International Introduction and Business Overview
7.1.3 Baxter International Hemoperfusion Cartridge Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Baxter International Hemoperfusion Cartridge Product Offerings
7.1.5 Baxter International Recent Developments
7.2 Asahi Kasei Corporation
7.2.1 Asahi Kasei Corporation Company Information
7.2.2 Asahi Kasei Corporation Introduction and Business Overview
7.2.3 Asahi Kasei Corporation Hemoperfusion Cartridge Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Asahi Kasei Corporation Hemoperfusion Cartridge Product Offerings
7.2.5 Asahi Kasei Corporation Recent Developments
7.3 Toray Medical
7.3.1 Toray Medical Company Information
7.3.2 Toray Medical Introduction and Business Overview
7.3.3 Toray Medical Hemoperfusion Cartridge Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Toray Medical Hemoperfusion Cartridge Product Offerings
7.3.5 Toray Medical Recent Developments
7.4 Jafron Biomedical
7.4.1 Jafron Biomedical Company Information
7.4.2 Jafron Biomedical Introduction and Business Overview
7.4.3 Jafron Biomedical Hemoperfusion Cartridge Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Jafron Biomedical Hemoperfusion Cartridge Product Offerings
7.4.5 Jafron Biomedical Recent Developments
7.5 Kaneka Medix Corporation
7.5.1 Kaneka Medix Corporation Company Information
7.5.2 Kaneka Medix Corporation Introduction and Business Overview
7.5.3 Kaneka Medix Corporation Hemoperfusion Cartridge Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Kaneka Medix Corporation Hemoperfusion Cartridge Product Offerings
7.5.5 Kaneka Medix Corporation Recent Developments
7.6 CytoSorbents
7.6.1 CytoSorbents Company Information
7.6.2 CytoSorbents Introduction and Business Overview
7.6.3 CytoSorbents Hemoperfusion Cartridge Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 CytoSorbents Hemoperfusion Cartridge Product Offerings
7.6.5 CytoSorbents Recent Developments
7.7 Baihe Medical
7.7.1 Baihe Medical Company Information
7.7.2 Baihe Medical Introduction and Business Overview
7.7.3 Baihe Medical Hemoperfusion Cartridge Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Baihe Medical Hemoperfusion Cartridge Product Offerings
7.7.5 Baihe Medical Recent Developments
8 Industry Chain Analysis
8.1 Hemoperfusion Cartridge Industrial Chain
8.2 Hemoperfusion Cartridge Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Hemoperfusion Cartridge Sales Model
8.5.2 Sales Channels
8.5.3 Hemoperfusion Cartridge Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Hemoperfusion Cartridge market size was US$ 1082 million in 2025 and is forecast to reach a readjusted size of US$ 3163 million by 2032 with a CAGR of 16.8% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 78
USD 4250.00
(Single User License)
The global Hemoperfusion Cartridge market was valued at US$ 1082 million in 2025 and is anticipated to reach US$ 3163 million by 2032, at a CAGR of 16.8% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 114
USD 2900.00
(Single User License)
The global market for Hemoperfusion Cartridge was estimated to be worth US$ 940 million in 2024 and is forecast to a readjusted size of US$ 2747 million by 2031 with a CAGR of 16.8% during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 104
USD 3950.00
(Single User License)
The global market for Hemoperfusion Cartridge was valued at US$ 940 million in the year 2024 and is projected to reach a revised size of US$ 2747 million by 2031, growing at a CAGR of 16.8% during the forecast period.
Published Date: 2025-02-07
Pages: 78
USD 2900.00
(Single User License)
The hemoperfusion device (that is, the disposable hemoperfusion device) is an essential key medical device for hemoperfusion.
Published Date: 2024-04-17
Pages: 141
USD 5600.00
(Single User License)
The hemoperfusion device (that is, the disposable hemoperfusion device) is an essential key medical device for hemoperfusion.
Published Date: 2024-04-16
Pages: 135
USD 5900.00
(Single User License)
The hemoperfusion device (that is, the disposable hemoperfusion device) is an essential key medical device for hemoperfusion.
Published Date: 2024-04-07
Pages: 88
USD 4900.00
(Single User License)
The hemoperfusion device (that is, the disposable hemoperfusion device) is an essential key medical device for hemoperfusion.
Published Date: 2024-01-18
Pages: 97
USD 3950.00
(Single User License)
The hemoperfusion device (that is, the disposable hemoperfusion device) is an essential key medical device for hemoperfusion.
Published Date: 2024-01-03
Pages: 78
USD 2900.00
(Single User License)
The global Hemoperfusion Cartridge market size was US$ 1082 million in 2025 and is forecast to reach a readjusted size of US$ 3163 million by 2032 with a CAGR of 16.8% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 78
The global Hemoperfusion Cartridge market was valued at US$ 1082 million in 2025 and is anticipated to reach US$ 3163 million by 2032, at a CAGR of 16.8% from 2026 to 2032.
Published: 2026-01-05
Pages: 114
The global market for Hemoperfusion Cartridge was estimated to be worth US$ 940 million in 2024 and is forecast to a readjusted size of US$ 2747 million by 2031 with a CAGR of 16.8% during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 104
The global market for Hemoperfusion Cartridge was valued at US$ 940 million in the year 2024 and is projected to reach a revised size of US$ 2747 million by 2031, growing at a CAGR of 16.8% during the forecast period.
Published: 2025-02-07
Pages: 78
The hemoperfusion device (that is, the disposable hemoperfusion device) is an essential key medical device for hemoperfusion.
Published: 2024-04-17
Pages: 141
The hemoperfusion device (that is, the disposable hemoperfusion device) is an essential key medical device for hemoperfusion.
Published: 2024-04-16
Pages: 135
The hemoperfusion device (that is, the disposable hemoperfusion device) is an essential key medical device for hemoperfusion.
Published: 2024-04-07
Pages: 88
The hemoperfusion device (that is, the disposable hemoperfusion device) is an essential key medical device for hemoperfusion.
Published: 2024-01-18
Pages: 97
The hemoperfusion device (that is, the disposable hemoperfusion device) is an essential key medical device for hemoperfusion.
Published: 2024-01-03
Pages: 78
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now